Holen Sie sich die Stockscreener-App
19.34
3.15%
0.59
Handel nachbörslich:
19.00
-0.34
-1.76%
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
36.10%
47.85
|
35.16 | 35.96 | 28.11 | 274.28 |
| Operating Income/Loss |
36.10%
-47.85
|
-35.16 | -35.96 | -28.11 | -274.28 |
| Nonoperating Income/Loss |
91.89%
-14.96
|
-184.43 | 1,758.82 | -784.58 | -1,299.38 |
| Net Income/Loss |
71.40%
-62.81
|
-219.59 | 1,722.86 | -812.68 | -1,573.67 |
| Basic Average Shares |
26.26%
54.30
|
43.01 | - | 6.6818 | 125.27 |
| Diluted Average Shares |
26.26%
54.30
|
43.01 | - | 6.6818 | 125.27 |
| Basic Earnings Per Share |
77.30%
-1.16
|
-5.11 | - | -121.63 | -12.56 |
| Diluted Earnings Per Share |
77.30%
-1.16
|
-5.11 | - | -121.63 | -12.56 |
4.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):